Apple secures a groundbreaking patent for oxygen saturation technology in smartwatches, enhancing health monitoring capabilities. This innovation aims to provide users with real-time blood oxygen level tracking, potentially revolutionizing wearable health tech by offering more accurate insights into wellness and fitness.
Image courtesy of tek.id
Global electronics giant APPLE has successfully pioneered the development of Oxygen Saturation technology for smartwatches. This marks a significant achievement for APPLE as a company that continuously develops cutting-edge technologies to support modern lifestyles.
Notably, the Blood Oxygen feature on APPLE devices allows users to measure their blood oxygen levels on demand directly from their wrist, providing insights into overall health.
Previously, the claim for the development of oxygen saturation technology led to controversy, culminating in a lawsuit filed by medical device maker Masimo against APPLE. This was confirmed by a publication from the Delaware District Court, which stated that Apple won the lawsuit filed by Masimo.
According to The Verge, on Saturday, November 2, APPLE requested only $250 in compensation, which is a relatively small amount. This figure was intentionally requested by Apple as a minimal compensation for the patent lawsuit.
As reported by Antaranews.com, it was known that at the end of 2023, the U.S. International Trade Commission had asked Apple to stop selling the Apple Watch Series 9 and Ultra 2, both of which featured the blood oxygen measurement function. As a result, the recently launched Apple Watch Series 10 did not include the same feature.
With the Delaware District Court ruling in favor of APPLE regarding the oxygen saturation patent, APPLE claims that this feature may appear in future generations of Apple smartwatches.
Like
Dislike
Love
Angry
Sad
Funny
Wow
Chinese New Year 2025, Feng Shui and Horoscope Insights with Lucky Numbers
January 05, 2025
Comments 0